Risk-adapted salvage treatment with single or tandem autologous stem-cell transplantation for first relapse/refractory Hodgkin's lymphoma: results of the prospective multicenter H96 trial by the GELA/SFGM study group.

Abstract

PURPOSE A prospective multicenter trial evaluated a risk-adapted salvage treatment with single or tandem autologous stem-cell transplantation (ASCT) for 245 Hodgkin's lymphoma (HL) patients who experience treatment failure with first-line therapy. PATIENTS AND METHODS Poor-risk patients (150 with primary refractory disease or > or = two of the following… (More)
DOI: 10.1200/JCO.2007.15.5887

Topics

Cite this paper

@article{Morschhauser2008RiskadaptedST, title={Risk-adapted salvage treatment with single or tandem autologous stem-cell transplantation for first relapse/refractory Hodgkin's lymphoma: results of the prospective multicenter H96 trial by the GELA/SFGM study group.}, author={Franck Morschhauser and Pauline Brice and Christophe Ferm{\'e} and Marine Divin{\'e} and Gilles Salles and R{\'e}da Bouabdallah and Catherine J Sebban and Laurent Voillat and Olivier Casasnovas and Aspasia Stamatoullas and Krimo Bouabdallah and Marc François Jean Andr{\'e} and Jean-Philippe Jais and Dominique Cazals-Hatem and Christian Gisselbrecht}, journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology}, year={2008}, volume={26 36}, pages={5980-7} }